OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

8 Projects | 5 Researchers | $1,174,229 Invested

2011

Mayo Clinic Florida

Guojun Bu, PhD

Targeting ApoE and ApoE Receptor Pathways for Alzheimer's Disease Therapy

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

Mayo Clinic Florida

Michael Hutton, PhD

Development of a cell-based platform for drug discovery in tauopathy

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

Mayo Clinic Florida

Leonard Petrucelli, PhD

Hsp70 Activity and Tau - A Therapeutic Target

  • Funding Amount: $75,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2004

Mayo Clinic Florida

Leonard Petrucelli, PhD

Hsp70 Activity and Tau A Therapeutic Target

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2004

Mayo Clinic Florida

Michael Hutton, PhD

In Vivo Testing of Compounds that Block the Development of Neurofibrillary Tau Pathology

  • Funding Amount: $196,662
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2002

Mayo Clinic Florida

Christopher Eckman, PhD

Natural Product Extracts that Reduce A-Beta Peptide Accumulation

  • Funding Amount: $250,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2001

Mayo Clinic Florida

Elliott Richelson, MD

Peptide Nucleic Acids Targeted to the Amyloid Precursor Protein

  • Funding Amount: $200,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2001

Mayo Clinic Florida

Christopher Eckman, PhD

Herbal Extracts that Reduce A-Beta Peptide Accumulation

  • Funding Amount: $127,567
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed